checkAd

    DGAP-News  135  0 Kommentare BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives - Seite 3


    BRAIN Biotech AG does not undertake any obligation to update or revise any forward-looking statements.

     

    Follow BRAIN Biotech on Twitter (@BRAINbiotech) and on LinkedIn (@BRAIN AG)


    15.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de

    Language: English
    Company: BRAIN Biotech AG
    Darmstädter Straße 34-36
    64673 Zwingenberg
    Germany
    Phone: +49 (0) 62 51 / 9331-0
    Fax: +49 (0) 62 51 / 9331-11
    E-mail: ir@brain-biotech.com
    Internet: www.brain-biotech.com
    ISIN: DE0005203947
    WKN: 520394
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1233740

     
    End of News DGAP News Service

    Lesen Sie auch

    1233740  15.09.2021 

    fncls.ssp?fn=show_t_gif&application_id=1233740&application_name=news&site_id=wallstreet
    Seite 3 von 3


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    DGAP-News BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives - Seite 3 DGAP-News: BRAIN Biotech AG / Key word(s): Capital Increase BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives 15.09.2021 / 21:51 The issuer is solely responsible for the content of this …